Cyclooxygenase
Products Related to Cyclooxygenase(517)
- GC4053215(R),19(R)-hydroxy Prostaglandin F2αCAS: 1224444-23-8Purity: >98.00%
19(R)-Hydroxylated prostaglandins (PGs) occur in μg/ml concentrations in the semen of certain mammalian species, especially primates.
- GC4053319(R)-hydroxy Prostaglandin F2αCAS: 64625-53-2Purity: >98.00%
19(R)-hydroxy PGF2α is an ω-1 hydroxylase metabolite of PGF2α found in human semen.
- GC4053420-hydroxy Prostaglandin F2αCAS: 57930-92-4Purity: >98.00%
20-hydroxy Prostaglandin F2α (20-hydroxy PGF2α) is the ω-oxidation product of PGF2α.
- GC405356,15-diketo-13,14-dihydro Prostaglandin F1αCAS: 63983-53-9Purity: >98.00%
6,15-diketo-13,14-dihydro PGF1α is a metabolite of PGI2.
- GC40537Thromboxane B2 MaxSpec® StandardCAS: 54397-85-2Purity: >98.00%
Thromboxane B2 (TXB2) is a stable, biologically inert metabolite formed from the non-enzymatic hydrolysis of TXA2, which has a half-life of about 30 seconds.
- GC4057711β-13,14-dihydro-15-keto Prostaglandin F2αCAS: 107615-77-0Purity: >95.00%
11β-13,14-dihydro-15-keto Prostaglandin F2α (11β-13,14-dihydro-15-keto PGF2α) is a metabolite of Prostaglandin D2 (PGD2) in the 15-hydroxy PGDH pathway.
- GC4057813,14-dihydro-15-keto Prostaglandin D1CAS: 1392219-79-2Purity: >98.00%
Prostaglandin D1 (PGD1) is the theoretical D-series metabolite of dihomo-γ-linolenic acid (DGLA), but to date it has not been isolated as a natural product.
- GC4058013,14-dihydro-15-keto Prostaglandin F2α MaxSpec® StandardCAS: 27376-76-7Purity: >95.00%
13,14-dihydro-15-keto Prostaglandin F2α (13,14-dihydro-15-keto PGF2α) is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway.
- GC4058115(R)-Prostaglandin F2αCAS: 37658-84-7Purity: >98.00%
15(R)-PGF2α is the C-15 epimer of the naturally occurring mammalian autacoid PGF2α.
- GC4058215-keto Prostaglandin F1αCAS: 21562-58-3Purity: >98.00%
15-keto PGF1α is the initial metabolite of PGF1α via 15-hydroxy PGDH.
- GC405835-trans Prostaglandin F2αCAS: 36150-01-3Purity: >98.00%
5-trans PGF2α is the more thermodynamically stable C-5 olefin isomer of PGF2α and is a common impurity in commercial lots of PGF2α.
- GC405845-trans Prostaglandin F2βCAS: 36150-02-4Purity: >98.00%
5-trans PGF2β is the 9β-hydroxy isomer of 5-trans PGF2α.
- GC405856α-Prostaglandin I1CAS: 62777-90-6Purity: >99.00%
6α-Prostaglandin I1 (6α-PGI1) is a stable Prostaglandin I2 (PGI2) analog resistant to hydrolysis in aqueous solutions.
- GC405866β-Prostaglandin I1CAS: 62770-50-7Purity: >99.00%
6β-PGI1 is a stable PGI2 analog resistant to hydrolysis in aqueous solutions.
- GC40592Prostaglandin F2β MaxSpec® StandardCAS: 4510-16-1Purity: 99.00%
Prostaglandin F2β (PGF2β) is the 9β-hydroxy stereoisomer of PGF2α.
- GC4060515-keto Prostaglandin E2CAS: 26441-05-4Purity: >98.00%
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH.
- GC4060615-keto Prostaglandin E2 MaxSpec® StandardCAS: 26441-05-4Purity: >98.00%
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH.
- GC40610Prostaglandin D3CAS: 71902-47-1Purity: >98.00%
Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway.
- GC40611Prostaglandin E3CAS: 802-31-3Purity: >98.00%
Prostaglandin E3 (PGE3) is formed via the cyclooxygenase (COX) metabolism of eicosapentaenoic acid.
- GC4062513,14-dihydro-15-keto-tetranor Prostaglandin D2CAS: 1204116-69-7Purity: >95.00%
A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs.
- GC4062613,14-dihydro-15-keto-tetranor Prostaglandin E2CAS: 20675-85-8Purity: >95.00%
A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs.
- GC4064815(R)-17-phenyl trinor Prostaglandin F2α ethyl amideCAS: 1163135-92-9Purity: >98.00%
15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide (15(R)-17-phenyl trinor PGF2α ethyl amide) is an isomer of bimatoprost, characterized by an inverted (β) hydroxyl group at C-15.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC40532 | 15(R),19(R)-hydroxy Prostaglandin F2α | 1224444-23-8 | >98.00% | |
19(R)-Hydroxylated prostaglandins (PGs) occur in μg/ml concentrations in the semen of certain mammalian species, especially primates. | ||||
| GC40533 | 19(R)-hydroxy Prostaglandin F2α | 64625-53-2 | >98.00% | |
19(R)-hydroxy PGF2α is an ω-1 hydroxylase metabolite of PGF2α found in human semen. | ||||
| GC40534 | 20-hydroxy Prostaglandin F2α | 57930-92-4 | >98.00% | |
20-hydroxy Prostaglandin F2α (20-hydroxy PGF2α) is the ω-oxidation product of PGF2α. | ||||
| GC40535 | 6,15-diketo-13,14-dihydro Prostaglandin F1α | 63983-53-9 | >98.00% | |
6,15-diketo-13,14-dihydro PGF1α is a metabolite of PGI2. | ||||
| GC40537 | Thromboxane B2 MaxSpec® Standard | 54397-85-2 | >98.00% | |
Thromboxane B2 (TXB2) is a stable, biologically inert metabolite formed from the non-enzymatic hydrolysis of TXA2, which has a half-life of about 30 seconds. | ||||
| GC40565 | Feprazone | 30748-29-9 | >98.00% | |
Feprazone (DA2370; Prenazone), ein Analogon von Phenylbutazon, ist ein nichtsteroidales entzÜndungshemmendes Mittel mit analgetischer und fiebersenkender Wirkung. | ||||
| GC40577 | 11β-13,14-dihydro-15-keto Prostaglandin F2α | 107615-77-0 | >95.00% | |
11β-13,14-dihydro-15-keto Prostaglandin F2α (11β-13,14-dihydro-15-keto PGF2α) is a metabolite of Prostaglandin D2 (PGD2) in the 15-hydroxy PGDH pathway. | ||||
| GC40578 | 13,14-dihydro-15-keto Prostaglandin D1 | 1392219-79-2 | >98.00% | |
Prostaglandin D1 (PGD1) is the theoretical D-series metabolite of dihomo-γ-linolenic acid (DGLA), but to date it has not been isolated as a natural product. | ||||
| GC40580 | 13,14-dihydro-15-keto Prostaglandin F2α MaxSpec® Standard | 27376-76-7 | >95.00% | |
13,14-dihydro-15-keto Prostaglandin F2α (13,14-dihydro-15-keto PGF2α) is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway. | ||||
| GC40581 | 15(R)-Prostaglandin F2α | 37658-84-7 | >98.00% | |
15(R)-PGF2α is the C-15 epimer of the naturally occurring mammalian autacoid PGF2α. | ||||
| GC40582 | 15-keto Prostaglandin F1α | 21562-58-3 | >98.00% | |
15-keto PGF1α is the initial metabolite of PGF1α via 15-hydroxy PGDH. | ||||
| GC40583 | 5-trans Prostaglandin F2α | 36150-01-3 | >98.00% | |
5-trans PGF2α is the more thermodynamically stable C-5 olefin isomer of PGF2α and is a common impurity in commercial lots of PGF2α. | ||||
| GC40584 | 5-trans Prostaglandin F2β | 36150-02-4 | >98.00% | |
5-trans PGF2β is the 9β-hydroxy isomer of 5-trans PGF2α. | ||||
| GC40585 | 6α-Prostaglandin I1 | 62777-90-6 | >99.00% | |
6α-Prostaglandin I1 (6α-PGI1) is a stable Prostaglandin I2 (PGI2) analog resistant to hydrolysis in aqueous solutions. | ||||
| GC40586 | 6β-Prostaglandin I1 | 62770-50-7 | >99.00% | |
6β-PGI1 is a stable PGI2 analog resistant to hydrolysis in aqueous solutions. | ||||
| GC40592 | Prostaglandin F2β MaxSpec® Standard | 4510-16-1 | 99.00% | |
Prostaglandin F2β (PGF2β) is the 9β-hydroxy stereoisomer of PGF2α. | ||||
| GC40605 | 15-keto Prostaglandin E2 | 26441-05-4 | >98.00% | |
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH. | ||||
| GC40606 | 15-keto Prostaglandin E2 MaxSpec® Standard | 26441-05-4 | >98.00% | |
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH. | ||||
| GC40610 | Prostaglandin D3 | 71902-47-1 | >98.00% | |
Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway. | ||||
| GC40611 | Prostaglandin E3 | 802-31-3 | >98.00% | |
Prostaglandin E3 (PGE3) is formed via the cyclooxygenase (COX) metabolism of eicosapentaenoic acid. | ||||
| GC40625 | 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | 1204116-69-7 | >95.00% | |
A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. | ||||
| GC40626 | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | 20675-85-8 | >95.00% | |
A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. | ||||
| GC40627 | tetranor-Misoprostol | - | >95.00% | |
tetranor-Misoprostol is a metabolite of misoprostol. | ||||
| GC40648 | 15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide | 1163135-92-9 | >98.00% | |
15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide (15(R)-17-phenyl trinor PGF2α ethyl amide) is an isomer of bimatoprost, characterized by an inverted (β) hydroxyl group at C-15. | ||||